Thank you, Dr. Gralow. It was truly our honor to recognize your exceptional leadership and lifelong dedication to advancing global oncology. Your commitment to mentorship, collaboration, and improving cancer care continues to inspire us and so many others around the world.
MedNews Week will be on the ground in New York City starting tomorrow for the 44th Annual Chemotherapy Foundation Symposium (#CFS2026)! 🗽
Led by Dr. Yan Leyfman, our team will be bringing you the latest insights, expert perspectives, and engaging conversations on emerging advances in cancer research and treatment.
Looking forward to seeing our team connect with leaders in oncology and share meaningful discussions with the global medical community.
Stay tuned for exclusive coverage from NYC!
@MedNewsWeek@YLeyfman@shahzeenkadir1@The_Noam_Levi@OncLive#MedNewsWeek#Oncology#CFS2026
🚨 The 44th Annual Chemotherapy Foundation Symposium is approaching!
Yan Leyfman, MD (@YLeyfman), will be live on the scene. Stay tuned tomorrow!
#Oncology#Cancer#CFS | @gotoPER
Excited to be attending the 44th Annual Chemotherapy Foundation Symposium (CFS 2026) in New York City!
Looking forward to connecting with leading voices in oncology, exploring the latest advances in cancer therapeutics, and bringing you insights directly from the meeting.
From emerging treatment strategies to innovations reshaping cancer care, I'll be sharing conversations with experts at the forefront of the field.
Grateful to the CancerNetwork, Onclive & PER team for the opportunity to help bring these important discussions to the broader oncology community.
Stay tuned for interviews, expert perspectives, and highlights from #CFS2026!
#Oncology#CancerResearch#CancerNetwork#CancerCare#MedicalInnovation#CFS2026@CancerNetwrk@gotoPER@OncLive
🚨 The 44th Annual Chemotherapy Foundation Symposium is approaching!
Yan Leyfman, MD (@YLeyfman), will be live on the scene. Stay tuned tomorrow!
#Oncology#Cancer#CFS | @gotoPER
Medical breakthroughs mean little if patients can’t access them. One of my key takeaways from Dr. @sghmd discussion at @MedNewsWeek was the need to bridge the gap between innovation and care delivery in stem cell transplantation.
🎥 Full discussion: youtu.be/B9ox7PRi74M?is=rvyp…
🧬 Beyond the Transplant
Better outcomes. Evolving GVHD management. Greater access to CAR-T.
Could rethinking the transplant system change what's possible for patients?
This week on @MedNewsWeek x @oncodaily hear from @sghmd Dr.Holtan
🎥 Watch: youtu.be/B9ox7PRi74M
🧬 94 allo-HCT recipients. 92.6% 1-year survival. Pharmaceutical costs per patient down >50% vs prior years. How? Two words: Systems redesign.
Want to dig deeper? Watch our @MedNewsWeek × @oncodaily keynote with Dr. Shernan Holtan (@sghmd)!
🎥 youtu.be/B9ox7PRi74M
What if the next breakthrough in transplantation isn't a new therapy- but better care delivery? Dr. @sghmd explores GVHD, access & system redesign in this @MedNewsWeek × @oncodaily keynote.
Watch: youtu.be/B9ox7PRi74M
🎙️ Advancing Cancer Innovation: Early Detection, Drug Discovery & Precision Medicine
Join MedNews Week for an insightful conversation with Dr. Shernan Holtan, Chief of Hematology and Cell Therapy at Allina Health and an internationally recognized leader in stem cell transplantation, cellular therapy, and GVHD research.
A pioneering physician-scientist whose contributions have helped shape modern transplantation practices and advance innovative cancer therapies, Dr. Holtan brings a unique perspective on translating scientific discoveries into meaningful improvements in patient care.
🔬 Explore the future of early cancer detection, drug discovery, and precision medicine, and the innovations transforming oncology.
▶️ Watch the full episode exclusively on OncoDaily TV: youtube.com/watch?v=B9ox7PRi…#MedNewsWeek#ShernanHoltan#PrecisionMedicine#CancerResearch#DrugDiscovery#CellTherapy#Oncology#WomenInMedicine
🎙️ Advancing Cancer Innovation: Early Detection, Drug Discovery & Precision Medicine
Join MedNews Week for an insightful conversation with Dr. Shernan Holtan, Chief of Hematology and Cell Therapy at Allina Health and an internationally recognized leader in stem cell transplantation, cellular therapy, and GVHD research.
A pioneering physician-scientist whose contributions have helped shape modern transplantation practices and advance innovative cancer therapies, Dr. Holtan brings a unique perspective on translating scientific discoveries into meaningful improvements in patient care.
🔬 Explore the future of early cancer detection, drug discovery, and precision medicine, and the innovations transforming oncology.
▶️ Watch the full episode exclusively on OncoDaily TV: youtube.com/watch?v=B9ox7PRi…#MedNewsWeek#ShernanHoltan#PrecisionMedicine#CancerResearch#DrugDiscovery#CellTherapy#Oncology#WomenInMedicine
The future of oncology depends not only on scientific progress, but on making advances accessible to all.
From AI-powered discoveries to personalized treatments, Dr. @dougflora2 discusses what lies ahead for cancer care.
@MedNewsWeek × @oncodaily :
youtu.be/27o9ewea0X4?si…
THE FUTURE OF CANCER CARE: INNOVATION, LEADERSHIP & PRECISION MEDICINE
What does it take to transform cancer care, advance early detection, and bring cutting-edge innovation to the patients who need it most?
At MedNews Week, we were honored to welcome Dr. Douglas Flora, MD, LSSBB, a nationally recognized oncology leader, innovator, and President of the Association of Cancer Care Centers (ACCC), for a special conversation on:
🔬 Early Cancer Detection, Drug Discovery & Precision Medicine
With over two decades of experience transforming oncology care, Dr. Flora has helped shape nationally recognized cancer screening programs, expand access to clinical trials, and champion the responsible integration of artificial intelligence into clinical oncology.
As a physician executive, researcher, author, and thought leader, his work exemplifies how visionary leadership and emerging technologies can converge to improve patient outcomes.
Our conversation explored the future of cancer detection, AI-driven innovation, precision oncology, and the challenges of translating scientific advances into meaningful, equitable patient care.
A heartfelt thank you to Dr. Flora for sharing his insights, leadership, and commitment to advancing cancer care and inspiring the next generation of innovators.
At MedNews Week, we believe the future of medicine is built through collaboration, innovation, and making knowledge accessible to all. 🌎
🎥 Catch this featured MedNews Week conversation on OncoDaily TV: youtube.com/watch?v=27o9ewea…#MedNewsWeek#DouglasFlora#Oncology#PrecisionMedicine#ArtificialIntelligence#CancerResearch#HealthcareLeadership#EarlyCancerDetection#MedicalInnovation
AI is changing what we can predict in cancer care. But will it change how we make decisions, too?
In this @MedNewsWeek x @OncLive , Dr. @dougflora2 explores the evolving intersection of oncology and AI.
The real Qs : how do we turn smarter technology into better patient care?
THE FUTURE OF CANCER CARE: INNOVATION, LEADERSHIP & PRECISION MEDICINE
What does it take to transform cancer care, advance early detection, and bring cutting-edge innovation to the patients who need it most?
At MedNews Week, we were honored to welcome Dr. Douglas Flora, MD, LSSBB, a nationally recognized oncology leader, innovator, and President of the Association of Cancer Care Centers (ACCC), for a special conversation on:
🔬 Early Cancer Detection, Drug Discovery & Precision Medicine
With over two decades of experience transforming oncology care, Dr. Flora has helped shape nationally recognized cancer screening programs, expand access to clinical trials, and champion the responsible integration of artificial intelligence into clinical oncology.
As a physician executive, researcher, author, and thought leader, his work exemplifies how visionary leadership and emerging technologies can converge to improve patient outcomes.
Our conversation explored the future of cancer detection, AI-driven innovation, precision oncology, and the challenges of translating scientific advances into meaningful, equitable patient care.
A heartfelt thank you to Dr. Flora for sharing his insights, leadership, and commitment to advancing cancer care and inspiring the next generation of innovators.
At MedNews Week, we believe the future of medicine is built through collaboration, innovation, and making knowledge accessible to all. 🌎
🎥 Catch this featured MedNews Week conversation on OncoDaily TV: youtube.com/watch?v=27o9ewea…#MedNewsWeek#DouglasFlora#Oncology#PrecisionMedicine#ArtificialIntelligence#CancerResearch#HealthcareLeadership#EarlyCancerDetection#MedicalInnovation
What if a patient misses a CAR-T clinical trial simply because no one identifies the opportunity?
At #LeukO2026, Dr. Yan Leyfman (@YLeyfman), showed how AI and mCODE could help clinicians find trial candidates faster, without replacing clinical judgment.
🔗 Read More: oncodaily.com/dialogues/yan-…@MedNewsWeek, @OncLive
What if we could reboot cancer care?
From AI-powered clinical trial matching to blood-based early detection and precision oncology, the future of cancer care is evolving.
But innovation alone isn’t enough. The real goal? Smarter tools, wider access, and more time for what matters most: patients.
Join @MedNewsWeek × @OncoDaily as Dr. Douglas B. Flora (@dougflora2) explores how technology can transform oncology while keeping humanity at the heart of medicine.
“Replace the mundane with the humane.”
Swipe through for key insights, and watch the full episode on YouTube:
youtu.be/27o9ewea0X4?is=6xi9…#MedNewsWeek#OncoDaily#RebootingCancerCare#Oncology#AIinHealthcare#PrecisionMedicine#CancerCare
What if AI’s greatest promise isn’t replacing physicians, but giving them more time to be physicians?
Join us on @MedNewsWeek’s latest Keynote with Dr. Douglas Flora, MD, LSSBB @dougflora2 , as we explore this timely question
🔗: youtu.be/27o9ewea0X4
comic ✨🎨 ➡️